Debiopharm has launched the IDEAL Japan initiative, a new program designed to provide financial support to Japanese academic ...

Agenus Inc., an immune-oncology company, has appointed José Iglesias, M.D. as Chief Medical Affairs Officer.

Thermo Fisher Scientific Inc. has opened its East Coast flagship Advanced Therapies Collaboration Center (ATxCC) in ...

Celltrion announced that the European Commission (EC) has granted marketing authorization for Remsima IV (intravenous) liquid ...

Halozyme Therapeutics has acquired Elektrofi, a biopharmaceutical company with a proprietary ultra-high concentration ...

BioDuro has launched a new Business Unit dedicated to advancing peptide drug discovery and development for its global biopharma partners.

Tyruko will be commercialized in the U.S. by its collaboration partner Sandoz, under an exclusive global license agreement. Polpharma Biologics S.A., operating under the Rezon Bio brand and ...